Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Interest Income | 599,347 | 715,062 | 766,978 | N/A | 387,811 |
| Interest Expense | 255,370 | 355,510 | 411,618 | 0 | 171,276 |
| Interest Income (Net of Interest Expense) | 343,977 | 359,552 | 355,360 | N/A | 216,535 |
| Non-Interest Income | 123,814 | 91,895 | 93,406 | N/A | 59,569 |
| Sales | 467,791 | 451,447 | 448,766 | 0 | 276,104 |
| Credit Losses Provision | 681,371 | 333,597 | 25,088 | N/A | 15,200 |
| Non Interest Expenses | 597,532 | 529,282 | 285,465 | N/A | 170,281 |
| Pre-tax Income | -811,112 | -411,432 | 138,213 | 0 | 90,623 |
| Income Tax | 26,982 | -75,898 | 44,924 | N/A | 29,404 |
| Other Income | -555,742 | -55,922 | 549,831 | 0 | 261,899 |
| Net Income | $-838,094 | $-335,534 | $93,289 | $N/A | $61,219 |
| EPS Basic Continuous Ops | -1,064.92 | -427.98 | 123.28 | N/A | 116.29 |
| EPS Basic Total Ops | -1,087.41 | -429.70 | 123.03 | N/A | 116.45 |
| EPS Diluted Continuous Ops | -1,064.92 | -427.98 | 122.22 | N/A | 114.96 |
| EPS Diluted Total Ops | -1,087.41 | -429.70 | 122.37 | N/A | 115.13 |
| EBITDA(a) | $N/A | $N/A | $N/A | $N/A | $N/A |